Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kerry Wentworth currently holds 152,250 shares of Flexion Therapeutics Inc (FLXN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kerry Wentworth has been a net seller of FLXN stock. They have purchased $0 and sold $851.7K worth of shares.
Kerry Wentworth's most recent insider trade was on Jun 23, 2026, when they sold 63,000 shares at $0.00 per share.
Kerry Wentworth serves as Executive at Flexion Therapeutics Inc (FLXN). They have executed 78 insider transactions totaling $851.7K over their tenure at the company.
Kerry Wentworth holds the position of Executive at Flexion Therapeutics Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Kerry Wentworth has shown a selling trading pattern, with $0 in total purchases and $851.7K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kerry Wentworth was on Nov 19, 2021, when they sold $1.2M worth of FLXN shares. This transaction involved 140,843 shares at $8.50 per share.
Kerry Wentworth currently owns 152,250 shares of Flexion Therapeutics Inc (FLXN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kerry Wentworth's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kerry Wentworth has 78 Form 4 filings on record as an insider at Flexion Therapeutics Inc.
Set alerts for Kerry Wentworth and 40,000+ other insiders.